Clinical Trial Update: Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) and Diet in Inflammatory Bowel Disease (IBD) Patients [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating a GLP-1 receptor agonist with a diet intervention in Crohn's disease; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• GLP-1 receptor agonist

Snippet

Sponsor: University of Miami | Conditions: Crohn Disease | Phase 4 | Status: RECRUITING